Al-kuraishy HM, Sulaiman GM, Mohammed HA, Dawood RA, Albuhadily AK, Al-Gareeb AI, et al. Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus. Neuropsychopharmacol Reports. 2025;45:e12525.

Article  CAS  Google Scholar 

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Mohammed SG, Al-Gareeb AI, Albuhadily AK, et al. Amyloid-β and heart failure in Alzheimer’s disease: the new vistas. Front Med. 2025;12:1494101.

Article  Google Scholar 

Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118:535–46.

Article  CAS  PubMed  Google Scholar 

Alexander Y, Osto E, Schmidt-Trucksäss A, Shechter M, Trifunovic D, Duncker DJ, et al. Endothelial function in cardiovascular medicine: a consensus paper of the European society of cardiology working groups on atherosclerosis and vascular biology, aorta and peripheral vascular diseases, coronary pathophysiology and microcirculation, and thrombosis. Cardiovasc Res. 2021;117:29–42.

Article  CAS  PubMed  Google Scholar 

Almohtasib Y, Fancher AJ, Sawalha K. Emerging Trends in Atherosclerosis: Time to Address Atherosclerosis From a Younger Age. Cureus. 2024;16:e56635. https://doi.org/10.7759/cureus.56635. 

Lechner K, von Schacky C, McKenzie AL, Worm N, Nixdorff U, Lechner B, et al. Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors. Eur J Prev Cardiol. 2020;27:394–406.

Article  PubMed  Google Scholar 

Farahi L, Sinha SK, Lusis AJ. Roles of macrophages in atherogenesis. Front Pharmacol. 2021;12:785220s.

Article  Google Scholar 

dos Santos VP, Pozzan G, Castelli Júnior V, Caffaro RA. Arteriosclerosis, atherosclerosis, arteriolosclerosis, and Monckeberg medial calcific sclerosis: what is the difference? J Vasc Bras. 2021;20:e20200211.

Article  PubMed  PubMed Central  Google Scholar 

Raitakari O, Pahkala K, Magnussen CG. Prevention of atherosclerosis from childhood. Nat Rev Cardiol. 2022;19:543–54.

Article  PubMed  Google Scholar 

Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, et al. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022;23:3346.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martos-Rodríguez CJ, Albarrán-Juárez J, Morales-Cano D, Caballero A, MacGrogan D, de la Pompa JL, et al. Fibrous caps in atherosclerosis form by notch-dependent mechanisms common to arterial media development. Arterioscler Thromb Vasc Biol. 2021;41:e427–39.

Article  PubMed  Google Scholar 

Porcu M, Anzidei M, Suri JS, Wasserman BA, Anzalone N, Lucatelli P, et al. Carotid artery imaging: The study of intra-plaque vascularization and hemorrhage in the era of the “vulnerable” plaque. J Neuroradiol. 2020;47:464–72.

Article  PubMed  Google Scholar 

Hasheminasabgorji E, Jha JC. Dyslipidemia, diabetes and atherosclerosis: role of inflammation and ROS-redox-sensitive factors. Biomedicines. 2021;9:1602.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73:924–67.

Article  CAS  PubMed  Google Scholar 

Mushenkova NV, Bezsonov EE, Orekhova VA, Popkova TV, Starodubova AV, Orekhov AN. Recognition of oxidized lipids by macrophages and its role in atherosclerosis development. Biomedicines. 2021;9:915.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mauersberger C, Hinterdobler J, Schunkert H, Kessler T, Sager HB. Where the action is—leukocyte recruitment in atherosclerosis. Front Cardiovasc Med. 2022;8:813984.

Article  PubMed  PubMed Central  Google Scholar 

Bugger H, Zirlik A. Anti-inflammatory strategies in atherosclerosis. Hamostaseologie. 2021;41:433–42.

Article  PubMed  Google Scholar 

Martinez GJ, Celermajer DS, Patel S. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. Atherosclerosis. 2018;269:262–71.

Article  CAS  PubMed  Google Scholar 

Chaldakov GN. Colchicine, a microtubule-disassembling drug, in the therapy of cardiovascular diseases. Cell Biol Int. 2018;42:1079–84.

Article  PubMed  Google Scholar 

Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther. 2006;8:1–5.

Article  Google Scholar 

Mayer T, Marx A. Five Molecules We Would Take to a Remote Island. Chem Biol. 2010;17:556–60.

Article  CAS  PubMed  Google Scholar 

Ozen S, Kone-Paut I, Gül A. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments. Semin Arthritis Rheum. 2017;47(1):115–20.

Article  CAS  PubMed  Google Scholar 

FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Rheumatol. 2020;72:879–95.

Article  PubMed  Google Scholar 

Nelson K, Fuster V, Ridker PM. Low-dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week. J Am Coll Cardiol. 2023;82:648–60.

Article  CAS  PubMed  Google Scholar 

El Hasbani G, Jawad A, Uthman I. Colchicine: An ancient drug with multiple benefits. Curr Pharm Des. 2021;27:2917–24.

Article  PubMed  Google Scholar 

Imai S, Momo K, Kashiwagi H, Miyai T, Sugawara M, Takekuma Y. Prescription of colchicine with other dangerous concomitant medications: a nation-wide survey using the Japanese claims database. Biol Pharm Bull. 2020;43:1519–25.

Article  CAS  PubMed  Google Scholar 

Stewart S, Yang KCK, Atkins K, Dalbeth N, Robinson PC. Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther. 2020;22:1–15.

Article  Google Scholar 

Niel E, Scherrmann J-M. Colchicine today. Jt Bone Spine. 2006;73:672–8.

Article  CAS  Google Scholar 

Gómez-Lumbreras A, Boyce RD, Villa-Zapata L, Tan MS, Hansten PD, Horn J, et al. Drugs that interact with colchicine via inhibition of cytochrome P450 3A4 and P-glycoprotein: a signal detection analysis using a database of spontaneously reported adverse events (FAERS). Ann Pharmacother. 2023;57:1137–46.

Article  PubMed  Google Scholar 

Jerschke E, Barkovsky M, Jung N, Neuberger H, Stenzel J, Eyer F, et al. In vivo neutralization of colchicine toxicity by a PASylated anticalin in a rat model. Toxicology. 2023;492:153526.

Article  CAS  PubMed  Google Scholar 

Sheibani M, Zamani N, Gerami AH, Akhondi H, Hassanian-Moghaddam H. Clinical, laboratory, and electrocardiographic findings in colchicine toxicity: 10 years of experience. Front Med. 2022;9:872528.

Article  Google Scholar 

Sun K, Sun Z, Zhao F, Shan G, Meng Q. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin. Future Med Chem. 2021;13:839–58.

Article  CAS  PubMed  Google Scholar 

Dvor̆ák Z, Modrianský M, Pichard-Garcia L, Balaguer P, Vilarem M-J, Ulrichová J, et al. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol Pharmacol. 2003;64:160–9.

Sanchez J. Colchicine and its effects on monocytes, macrophages, and inflammation. Digit Commons St Mary’s Univ y. 2020;147.

Nidorf SM, Ben-Chetrit E, Ridker PM. Low-dose colchicine for atherosclerosis: long-term safety. Eur Heart J. 2024;45:1596–601.

Article  CAS  PubMed  Google Scholar 

Kurup R, Galougahi KK, Figtree G, Misra A, Patel S. The Role of Colchicine in Atherosclerotic Cardiovascular Disease. Heart Lung Circ. 2021;30:795–806.

Article  PubMed